Pascal and Francis Bibliographic Databases

Help

Search results

Your search

cc.\*:("002B05C02I")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3531

  • Page / 142
Export

Selection :

  • and

Out of Africa: Ebola cases come to U.SRIBNER, Bruce; FRIEDEN, Tom; GEISBERT, Thomas et al.Hospital infection control & prevention. 2014, Vol 41, Num 9, pp 90-91, issn 1945-9653, 2 p.Article

A tribute to Sheik Humarr Khan and all the healthcare workers in West Africa who have sacrificed in the fight against Ebola virus disease: Mae we hushBAUSCH, Daniel G; BANGURA, James; GARRY, Robert F et al.Antiviral research. 2014, Vol 111, pp 33-35, issn 0166-3542, 3 p.Article

Association of ILIB ―31C/T and IL1RA Variable Number of an 86-bp Tandem Repeat With Dengue Shock Syndrome in ThailandSA-NGASANG, Areerat; OHASHI, Jun; NAKA, Izumi et al.The Journal of infectious diseases. 2014, Vol 210, Num 1, pp 138-145, issn 0022-1899, 8 p.Article

Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic feverCHEN, Rong-Fu; YANG, Kuender D; LEE, Ing-Kit et al.The Journal of infection. 2014, Vol 69, Num 4, pp 366-374, issn 0163-4453, 9 p.Article

Challenges encountered using standard vector control measures for dengue in Boa Vista, BrazilMACIEL-DE-FREITAS, Rafael; VALLE, Denise.Bulletin of the World Health Organization. 2014, Vol 92, Num 9, pp 685-689, issn 0042-9686, 5 p.Article

Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-BissauFISKER, Ane Bærent; RAVN, Henrik; RODRIGUES, Amabelia et al.Vaccine. 2014, Vol 32, Num 5, pp 598-605, issn 0264-410X, 8 p.Article

Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: Randomized study in toddlers in TaiwanHUANG, Li-Min; LIN, Tzou-Yien; CHIU, Cheng-Hsun et al.Vaccine. 2014, Vol 32, Num 41, pp 5363-5369, issn 0264-410X, 7 p.Article

Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra LeoneDAHMONE, A; VAN GRIENSVEN, J; VAN HERP, M et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014, Vol 108, Num 3, pp 126-132, issn 0035-9203, 7 p.Article

Dengue outbreaks: a constant risk for Reunion Island. Results from a seroprevalence study among blood donorsLARRIEU, Sophie; MICHAULT, Alain; POLYCARPE, Dominique et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014, Vol 108, Num 1, pp 57-59, issn 0035-9203, 3 p.Article

Diagnosis of dengue in Sri Lanka: improvements to the existing state of the art in the islandSENARATNE, Thamarasi N; NOORDEEN, Faseeha.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014, Vol 108, Num 11, pp 685-691, issn 0035-9203, 7 p.Article

Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambsBUSQUETS, Núria; LORENZO, Gema; GILBERT, Sarah C et al.Antiviral research. 2014, Vol 108, pp 165-172, issn 0166-3542, 8 p.Article

Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safetyBERAN, Jiří; FANG XIE; ZENT, Olaf et al.Vaccine. 2014, Vol 32, Num 34, pp 4275-4280, issn 0264-410X, 6 p.Article

Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDRNDILLE, Emmanuel Elanga; DUBOT-PERES, Audrey; DOUCOURE, Souleymane et al.TM & IH. Tropical medicine & international health. 2014, Vol 19, Num 5, pp 576-580, issn 1360-2276, 5 p.Article

Increased Risk of Acute Myocardial Infarction and Stroke During Hemorrhagic Fever With Renal Syndrome: A Self-Controlled Case Series StudyCONNOLLY-ANDERSEN, Anne-Marie; HAMMARGREN, Edvin; WHITAKER, Heather et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 12, pp 1295-1302, issn 0009-7322, 8 p.Article

Irregular tick-borne encephalitis vaccination schedules: The effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional studySCHOSSER, Rudolf; REICHERT, Anja; MANSMANN, Ulrich et al.Vaccine. 2014, Vol 32, Num 20, pp 2375-2381, issn 0264-410X, 7 p.Article

Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier productZAMAN, K; NASER, Abu Mohd; FLORES, Jorge et al.Vaccine. 2014, Vol 32, Num 46, pp 6061-6066, issn 0264-410X, 6 p.Article

Modelling interventions during a dengue outbreakBARMAK, D. H; DORSO, C. O; OTERO, M et al.Epidemiology and infection. 2014, Vol 142, Num 3, pp 545-561, issn 0950-2688, 17 p.Article

Nebraska biocontainment unit preparing for EbolaHEWLETT, Angela; SMITH, Philip W; BOULTER, Kate et al.Hospital infection control & prevention. 2014, Vol 41, Num 9, pp 94-95, issn 1945-9653, 2 p.Article

One Health approach to Rift Valley fever vaccine developmentKORTEKAAS, Jeroen.Antiviral research. 2014, Vol 106, pp 24-32, issn 0166-3542, 9 p.Article

Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in ChinaYALI WANG; DUO DONG; GANG CHENG et al.Vaccine. 2014, Vol 32, Num 44, pp 5875-5879, issn 0264-410X, 5 p.Article

Prospective Applicability Study of the New Dengue Classification System for Clinical Management in ChildrenLOVERA, Dolores; ARAYA, Soraya; MESQUITA, Maria Jose et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 9, pp 933-935, issn 0891-3668, 3 p.Article

The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries?MAHONEY, Richard.Vaccine. 2014, Vol 32, Num 8, pp 904-908, issn 0264-410X, 5 p.Article

Will people change their vector-control practices in the presence of an imperfect dengue vaccine?BOCCIA, T. M. Q. R; BURATTINI, M. N; COUTINHO, F. A. B et al.Epidemiology and infection. 2014, Vol 142, Num 3, pp 625-633, issn 0950-2688, 9 p.Article

Yellow fever risk assessment in the Central African RepublicSTAPLES, J. Erin; DIALLO, Mawlouth; JANUSZ, Kristen B et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014, Vol 108, Num 10, pp 608-615, issn 0035-9203, 8 p.Article

Yellow fever vaccine-associated adverse events following extensive immunization in ArgentinaBISCAYART, Cristián; PEREZ CARREGA, María Eugenia; UBOLDI, María Andrea et al.Vaccine. 2014, Vol 32, Num 11, pp 1266-1272, issn 0264-410X, 7 p.Article

  • Page / 142